CDDW™ 2022 Speaker Disclosures

CDDW 2022 - virtual2





Download a PDF of the below Speaker Disclosures here.

Najma AhmedNothing relevant to disclose
Joannie AllaireNothing relevant to disclose
Christopher AndrewsAvir Pharma, Advisory Board; Bausch Health, Advisory Board; Knight Pharma, Advisory Board; Abbvie, Advisory Board; Sandoz, Advisory BoardnNimble Science, Research support, Advisory Board, financial interest; Alimetry Inc., Consultant, financial interest
David Armstrong

Canadian Association of Gastroenterology - Role 1: Past-President, Board Member, Role 2: Research Grant. Nestlé Health Sciences - Role 1: Research Grant. Weston Family Foundation - Role 1: Research Grant. Canadian Partnership Against Cancer - Role 1: Expert Advisor, Stipend. International Working Group for the Classification of Oesophagitis - Role 1: Treasurer, Board Member, Stipend; Role 2: Consensus Conference Co-Lead, Stipend. Canadian Digestive Health Foundation - Role 1: Board Member, not remunerated. World Gastroenterology Organization - Role 1: Guidelines Chair, not remunerated. Takeda Canada - Role 1: Speaker, honorarium. Viatris - Role 1: Speaker, honorarium. Fresenius Kabi - Role 1: Speaker, honorarium. AI VALI Inc - Role 1: Scientific Advisory Board, not remunerated. Cinclus Pharma - Role 1: Scientific Advisory Board, not remunerated. Phathom Pharma - Role 1: Clinical Study Advisory Board, not remunerated

Heather ArmstrongNothing relevant to disclose
Marie-Claire ArrietaNothing relevant to disclose
Alan BarkunTakeda Inc., consultant and presenter
Eric Benchimol1. Hoffman La-Roche Limited and Peabody & Arnold LLP, legal consultant (for matters unrelated to vaccines or medication used to treat inflammatory bowel disease). 2. McKesson Canada, consultant.
Robert BergerMedtronic: Speakers panel; Vantage: Speakers panel; Janssen: Speakers panel; Abbvie: Advisory board; Takeda: Speakers panel; Advisory board; Pfizer: Advisory board; Bioadvance: Advisory board
Kirk BergstromNothing relevant to disclose
Charles Bernstein

Advisory board or consultant to Abbvie Canada, Amgen Canada, Avir Pharmaceuticals, Bristol Myers Squibb Canada, Janssen Canada, Pfizer Canada, Sandoz Canada, Roche Canada, JAMP Canada, Takeda; Speakers fees from Abbvie Canada, Janssen Canada, Pfizer; Canadian Educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada, Takeda Canada; Research grants from Abbvie Canada, Pfizer Canada, Amgen Canada, Sandoz Canada, Takeda Canada

Talat BessissowAdvisory board: Abbvie, Alimentiv, Amgen, Bristol Myers Squibb, Janssen, Pfizer, Roche, Sandoz, Takeda; Speaker: Janssen, Abbvie, Takeda, Ferring, Bristol Myers Squibb, Merck, Gilead, Viatris
Jorge BezerraGilead - Clinical trial for children with chronic HBV infection. Grant funds paid directly to Cincinnati Children's Hospital; DX4Liver - Consultation for biomarkers of liver disease
Alain BittonAdvisory Board: Janssen, Abbvie, Takeda, Hoffman Roche, Amgen, McKesson, Bristol Myers Squibb, Pfizer; Educational Activity: Fresenius Kabi, Janssen
Natasha BollegalaAbbvie - speaker fees, advisory boards; Takeda - speaker fees, advisory boards; Janssen - speaker fees, advisory boards; Crohn's and Colitis Canada - research support
Michael ByrneCEO and founder of Satisfai Health. Via a joint venture named ai4gi, Satisfai has a co-development agreement with Olympus America in colon polyps and artificial intelligence.
Alberto Caminero FernandezNothing relevant to disclose
Carla CoffinGrant support from Gilead Sciences, Inc., Janssen Pharmaceuticals, GSK (for the Canadian HBV Network).  Advisory Board member: Altimmune Pharmaceuticals, Janssen Pharmaceuticals (for the Canadian HBV Network)
Jean-Frederic ColombelJean-Frederic Colombel has received research grants from AbbVie, Janssen Pharmaceuticals and Takeda; has received payment for lectures from AbbVie, Amgen, Allergan, Bristol-Myers Squibb Company, Ferring Pharmaceuticals, Shire, and Takeda; has received consulting fees from AbbVie, Amgen, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Eli Lilly, Enterome, Ferring Pharmaceuticals, Genentech, Gilead, Iterative Scopes, Ipsen, Immunic, lmtbio, Inotrem, Janssen Pharmaceuticals, Landos, LimmaTech Biologics AG, Medimmune, Merck, Novartis, O Mass, Otsuka, Pfizer, Shire, Takeda, Tigenix, Viela bio; and hold stock options in Intestinal Biotech Development.
Giada De PalmaNothing relevant to disclose
Lee DensonNothing relevant to disclose
Levinus DielemanI have been a consultant and/or member of Advisory Board for Janssen, Abbvie, Ferring. I have also received grant support from Janssen, Abbvie, Pfizer as well as from the Jackson GI Foundation.
Kyle FlanniganNothing relevant to disclose
Jennifer FlemmingGilead - consulting on scientific conferencen planning
Nauzer ForbesBoston Scientific - 1) Consultancy fees 2) Speaker's fees; Pentax Medical - 1) Consultancy fees 2) Speaker's fees 3) Research funding; Pendopharm - 1) Consultancy fees
Catherine ForseNothing relevant to disclose
Jorg H. FritzNothing relevant to disclose
Heather GalipeauNothing relevant to disclose
Jean-Eric GhiaCanadian Broad Casting/Radio-Canada: Host, writer; WebOuest: Host, writer; LaLiberté: Host, writer
Véronique GirouxNothing relevant to disclose
Tanja Gonska1) Vertex Pharmaceutical Ind: consultation 2021 and contracted for conference participation in Nov 2021; 2) Abbvie: contracted for research experiments
Juan Gonzalez-AbraldesGrants: Gilead; Lecture fees: Lupin; Consulting Fees: Gilead, Genfit, Intercept, Inventiva, Boehringer-Ingelheim; None since November 2020
Karen GoodmanNothing relevant to disclose
Morris GordonNothing relevant to disclose
Leah Gramlichspeaker - abbott, baxter, FK, Takeda; consultant - abbott, baxter, FK, Takeda; research funding - baxter, FK, Takeda
Alex GregorieffNothing relevant to disclose
Jennifer HalaszNothing relevant to disclose
Xiao HanNothing relevant to disclose
Jenna HaverfieldNothing relevant to disclose
DeBroski HerbertNothing relevant to disclose
Simon HirotaNothing relevant to disclose
Lawrence HookeyPendopharm Canada, speaking fees/ consultant
John IgoeAbbVie- Speaker/Consultant; Janssen- Speaker/Consultant; Gilead- Speaker/Consultant; Intercept- Speaker; Merck- Consultant; Pfizer- Speaker/Consultant; Takeda- Speaker/Consultant; Lupin- Speaker/Consultant; Knight Pharmaceuticals- Speaker/Consultant
Nicola JonesNothing relevant to disclose
Klaus KaestnerNothing relevant to disclose
Mohit KeharNothing relevant to disclose
Reena KhannaRK reports fees for Consulting/Speaking from: AbbVie, Amgen, Encycle, Innomar, Gilead, Janssen, Lilly, Merck, Pendopharm, Pfizer, Roche/Genetech, Alimentiv (formerly Robarts Clinical Trials), Shire, and Takeda Canada outside the submitted work; Research fees from Roche/Genetech.
Irah KingNothing relevant to disclose
Narjis KraimiNothing relevant to disclose
Peter LakatosPLL has been a speaker and/or advisory board member: AbbVie, Amgen, Arena Pharmaceuticals, Fresenius Kabi, Genetech, Gilead, Janssen, Merck, Mylan, Organon, Pharmacosmos, Pfizer, Roche, Takeda ,Tillots and Viatris and has received unrestricted research grant: AbbVie, Gilead, Takeda and Pfizer.
Adriana LazarescuBausch - advisory board; Knight - advisoryn board
Desmond LeddinNothing relevant to disclose
Sun-Ho LeeNothing relevant to disclose
Grigorios LeontiadisCanadian Association of Gastroenterology, role 3 (volunteer work as VP Clinical Affairs)
Qiaochu LiangNothing relevant to disclose
Louis LiuAbbVie, Medtronic, Lupin, Knight, Bausch Health as a speaker and consultant; Allergan as a speaker and consultant, as well as receive research funding.
Donald MacIntoshAd Board Pendopharm
David MackNothing relevant to disclose
Wallace MacNaughtonNothing relevant to disclose
Karen MadsenNothing relevant to disclose
Nathalia MalaccoNothing relevant to disclose
John MarshallConsultant: AbbVie, Alimentiv, Allergan, Amgen, Bausch Health, Bristol Myers Squibb, Ferring, Fresenius Kabi, Janssen, Lilly, Lupin, Novartis, Organon, Paladin, Pfizer, Pharmascience, Qu Biologics, Roche, Sandoz, Takeda, Teva, Viatris; Speaker: AbbVie, Allergan, Amgen, Ferring, Janssen, Lupin, Organon, Pfizer, Pharmascience, Roche, Takeda, Viatris
Gary MayOlympus - consultant; Medtronic - speaker; Vantage endoscopy - consultant; Cook Canada - consultant; Boston Scientific - consultant and speaker
Jeffrey McCurdyAdd-board: Pfizer, AbbVie, Takeda, Janssen, BMS, Fresenius Kabi; Speaker fees: Abbivie, Takeda, Janssen
Derek McKayNothing relevant to disclose
Leanna McKenzieNothing relevant to disclose
Charles MénardPendopharm role 1; presenter, role 2 advisory board participant; Chess Medical: consultant; Pentax; presenter
Mar MiserachsNothing relevant to disclose
Suresh MishraNothing relevant to disclose
Tina MontreuilNothing relevant to disclo
Aleixo MuiseNothing relevant to disclose
Yasmin NasserAbbvie - Speaker fees; Allergan - advisory board member, speaker fees, clinical trial/research funding
Geoffrey NguyenAbbvie - advisory board; Takeda - advisory board
Kerri NovakKerri Novak reports advisory board fees from AbbVie, Janssen, Pfizer, Ferring, Takeda; speaker’s fees from AbbVie, Janssen, Takeda, Pfizer; and research support from AbbVie and educational support from Pfizer.
Anthony OtleyAbbVie - grant support, consultant, Advisory Board; Janssen - Advisory Board; Eli-Lilly- study site; Pfizer - study site, consultant
John PandolfinoTorax/Ethicon: Speaking/Consulting; Takeda: Speaking; Impleo: Grant; Trimedyne- Stock Options; Alfasigma - Consulting; Endogastric Solutions - Consulting/Speaking
Nathalie PerreaultNothing relevant to disclose
Maria Ines Pinto-SanchezNothing relevant to disclose
Dan PoindexterI am an employee of Oxford University Press, a non-profit academic publishing company.
Véronique PomerleauNothing relevant to dislose
Julien PujoNothing relevant to disclose
William ReesNothing relevant to disclose
Douglas K. RexConsultant: Olympus Corporation, Boston Scientific, Aries Pharmaceutical, Braintree Laboratories, Lumendi, Ltd., Norgine, Endokey, GI Supply, Medtronic, *Acacia Pharmaceuticals; Research Support: EndoAid, Olympus Corporation, Medivators, Erbe USA Inc, Braintree Laboratories; Shareholder: Satisfai Health
Lisa ReynoldsNothing relevant to disclose
David RodriguesNothing relevant to disclose
Alaa RostomNothing relevant to disclose
Zarwa SaqibNothing relevant to disclose
Giada SebastianiSpeaker, advisory board member: Merck, Gilead, Novartis, Novonordisk, Pfizer, Allergan, Intercept; Speaker: Abbvie, Merck, Gilead, Clinical Care Options; Unrestricted research funds: Merck, Theratec Since 2019
Cynthia SeowAdvisory Boards: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Sandoz, Pharmascience, Fresenius Kabi, Amgen; Speaker: Janssen, Abbvie, Takeda, Ferring, Shire, Pfizer, Pharmascience; Research: Takeda
Elizabeth SicilianiNothing relevant to disclose
Harminder SinghI have been on advisory board/ consulted to Amgen Canada, Bristol-Myers Squibb Canada, Sandoz Canada, Roche Canada, Takeda Canada, Pendopharm; Ferring Canada and Guardant Health Inc.,
Sidhartha SinhaNothing relevant to disclose
Laura SlyNothing relevant to disclose
Harry SokolConsulting: Ferring, MSD, Enterome, BiomX; Conference: Abbvie, Novartis, Takeda, MSD, Ferring, Biocodex, Mayoly Spindler; Co-funder: Exeliom Biosciences
Theodore SteinerQu Biologics: employee (Medical Director, Infectious Diseases); Ferring: Consultant; Verity: Consultant; Avir: Consultant; Merck: Grant funding; Rebiotix, Series, Summit, Edesa: Clinical trial funding; Bold Therapeutics: research funding (Mitacs)
Michael StewartConsultant: Abbvie, Takeda, Janssen, Pfizer, Sandoz, Amgen. Speaker: Abbvie, Janssen, Amgen.  Research: Takeda, Abbvie, Janssen, Genentech, Gilead.
Mark SwainAdvisory board: Gilead, Intercept, Novartis nSpeaker: Gilead, Intercept, AbbottnClinical trial or research support: Gilead, BMS, CymaBay, Intercept, Genfit, Pfizer, Novartis, Astra Zeneca, GSK, Celgene, Novo Nordisk, Axcella Health Inc., Merck, Galectin Therapeutics
Lee-Hwa TaiNothing relevant to disclose
Laura TargownikAmgen: advisory board; Abbvie: advisory board; Janssen: advisory board; Takeda: study support, advisory board, educational material; Pfizer: study support, advisory board, authorship team; Sandoz: study support, advisory board; Celltrion: advisory board
Jennifer TelfordPendopharm, advisory board member
Carolina TropiniNothing relevant to disclose
Justine TurnerResearch funding Baxter; Research funding Vetanda
Williams TurpinNothing relevant to disclose
Sander Veldhuyzen van ZantenNothing relevant to disclose
Elena VerduBiocodex: Scientific Advisory Board, grant recipient; Gilead: grant recipient; CCC: grant recipient; Kalioppe: grant recipient
Catharine WalshNothing relevant to disclose
Kevin WaschkePendopharm- speaker
Adam WeizmanAbbvie: advisory board, speaker; Janssen: advisory board, speaker; Takeda: advisory board; Novartis: advisory board
Chadwick WilliamsAbbvie - speaker's bureau, advisory board member, lecturer; Janssen - speaker's bureau, advisory board member, lecturer; Pfizer -speaker's bureau, advisory board member; Takeda - speaker's bureau, advisory board member, lecturer
Brian YanAbbvie - Consulting honorarium; Takeda - Consulting honorarium; Janssen - Consulting honorarium; Pharmascience - Consulting honorarium; CAG - Honorarium; Royal College of Physicians and Surgeons of Canada - Honorarium